The Hain Celestial Group (HAIN)
(Delayed Data from NSDQ)
$8.92 USD
+0.27 (3.12%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $8.92 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.92 USD
+0.27 (3.12%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $8.92 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Hain Celestial (HAIN) Down 8.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Hain Celestial (HAIN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hain Celestial (HAIN) Falls Despite Q3 Earnings & Sales Beat
by Zacks Equity Research
Hain Celestial's (HAIN) top and bottom lines decline year over year in third-quarter fiscal 2019. Net sales decline across all regions.
Hain Celestial (HAIN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of 5.00% and 1.01%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Hain Celestial (HAIN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Hain Celestial (HAIN) is concerned about sluggish sales performance across the United States, United Kingdom and Rest of World along with soft margins.
Analysts Estimate Hain Celestial (HAIN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Project Terra to Aid Hain Celestial, Drab FY19 View Hurts
by Zacks Equity Research
Hain Celestial (HAIN) is expected to gain from its Project Terra program and strategic acquisitions amid muted FY19 guidance and soft margins.
Hain Celestial (HAIN) Down on Weak FY19 Outlook & Soft Margin
by Zacks Equity Research
Hain Celestial's (HAIN) dismal top line and high freight costs are concerns. However, Project Terra is likely to provide cushion to the stock.
Why Is Hain Celestial (HAIN) Up 33.1% Since Last Earnings Report?
by Zacks Equity Research
Hain Celestial (HAIN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hain Celestial (HAIN) Surges: Stock Moves 5.9% Higher
by Zacks Equity Research
Hain Celestial (HAIN) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Hain Celestial's (HAIN) Q2 Earnings Decline Y/Y, View Slashed
by Zacks Equity Research
Hain Celestial's (HAIN) top and bottom lines decline year over year and continue with the negative surprise trend in Q2. Further, management slashes fiscal 2019 outlook.
Hain Celestial (HAIN) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -46.15% and -4.56%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Hain Celestial (HAIN) Earnings Continue to Fall in Q2?
by Zacks Equity Research
While freight and commodity cost woes are expected to linger, Project Terra program is likely to provide cushion to Hain Celestial (HAIN) in Q2.
Earnings Preview: Hain Celestial (HAIN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Hain Celestial's Strategic Efforts Lead to a Turnaround?
by Zacks Equity Research
Hain Celestial's (HAIN) soft U.S. segment sales and high freight costs are concerns. However, Project Terra program and acquisitions are likely to provide cushion to the stock.
Why Is Hain Celestial (HAIN) Down 14.3% Since Last Earnings Report?
by Zacks Equity Research
Hain Celestial (HAIN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hain Celestial (HAIN) Falls on Q1 Earnings Miss, Decline Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) commenced fiscal 2019 on a soft note, wherein both the top and bottom lines fell short of the Zacks Consensus Estimate.
Hain Celestial (HAIN) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -30.77% and -4.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Sales Leaders & Customers to Aid Nu Skin's (NUS) Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) Q3 performance to gain from a sturdy base of sales leaders and customers. Projections for the impending quarter unveil a favorable picture.
Factors Likely to Influence Meredith's (MDP) Q1 Earnings
by Zacks Equity Research
While strategic buyouts and restructuring actions serve as key growth drivers for Meredith (MDP), soft EBITDA margins may be a deterrent.
Hain Celestial (HAIN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Hain Celestial (HAIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medifast (MED) Q3 Earnings: Coaches & OPTAVIA are Key Drivers
by Zacks Equity Research
Medifast's (MED) Q3 performance to gain from a sturdy coach base and advancement in the OPTAVIA brand.
Will Soft Volumes Hurt TreeHouse Foods' (THS) Q3 Earnings?
by Zacks Equity Research
TreeHouse Foods (THS) struggles with higher input cost and soft volumes. However, the company is on track with its TreeHouse 2020 initiative and other efforts.
Factors That Hold Key to Hain Celestial (HAIN) Q1 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) Project Terra program is likely to improve productivity and facilitate cost reductions. However, any deleverage in freight and commodity expenses may weigh on margins.
Will Sprouts Farmers' (SFM) Earnings Continue to Rise in Q3?
by Zacks Equity Research
Sprouts Farmers (SFM) is trying all means to provide ready-to-eat, ready-to-heat, and ready-to-cook items to customers.
3 Food Stocks Set to Trump Estimates This Earnings Season
by Zacks Equity Research
Although high commodity costs are a concern for the food industry, few companies are likely to gain from savings and brand augmenting efforts.